instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,356,815 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriovenous malformation'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood loss anaemia'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dehydration'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric disorder'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,356,815 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatorenal syndrome'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Melaena'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oliguria'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Anaemia'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Recovering | ReactionOutcome | CC BY-NC | 34806443 | 20,356,815 | 2021 |
What was the outcome of reaction 'Arteriovenous malformation'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Asthenia'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Blood loss anaemia'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Gastric disorder'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Recovering | ReactionOutcome | CC BY-NC | 34806443 | 20,356,815 | 2021 |
What was the outcome of reaction 'Hepatorenal syndrome'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Oliguria'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
What was the outcome of reaction 'Renal failure'? | From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percu... | Fatal | ReactionOutcome | CC BY-NC | 34806443 | 20,157,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | ACETAMINOPHEN | DrugsGivenReaction | CC BY-NC-ND | 34807902 | 20,205,832 | 2021-11-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angina pectoris'. | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | ACETAMINOPHEN | DrugsGivenReaction | CC BY-NC-ND | 34807902 | 20,205,832 | 2021-11-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial infarction'. | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | ACETAMINOPHEN | DrugsGivenReaction | CC BY-NC-ND | 34807902 | 20,205,832 | 2021-11-22 |
What was the administration route of drug 'ACETAMINOPHEN\HYDROCODONE BITARTRATE'? | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34807902 | 20,240,340 | 2021-11-22 |
What was the outcome of reaction 'Acute myocardial infarction'? | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34807902 | 20,205,832 | 2021-11-22 |
What was the outcome of reaction 'Angina pectoris'? | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34807902 | 20,205,832 | 2021-11-22 |
What was the outcome of reaction 'Kounis syndrome'? | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34807902 | 20,195,467 | 2021-11-22 |
What was the outcome of reaction 'Myocardial infarction'? | A Case of Kounis Syndrome Presenting as Coronary Artery Spasm Associated with Acetaminophen Infusion.
BACKGROUND Kounis syndrome is a hypersensitive coronary disorder triggered by drugs, food, and environmental factors. A 38-year-old male patient with acetaminophen-induced type 1 Kounis syndrome is described. The purpo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34807902 | 20,205,832 | 2021-11-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | AMLODIPINE BESYLATE, IBUPROFEN | DrugsGivenReaction | CC BY | 34809625 | 20,221,400 | 2021-11-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'False positive investigation result'. | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | IBUPROFEN, LINEZOLID, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY | 34809625 | 20,302,176 | 2021-11-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | AMLODIPINE BESYLATE, IBUPROFEN, LINEZOLID, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY | 34809625 | 20,195,548 | 2021-11-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | IBUPROFEN, LINEZOLID, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY | 34809625 | 20,302,176 | 2021-11-22 |
What is the weight of the patient? | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | 68.4 kg. | Weight | CC BY | 34809625 | 20,221,400 | 2021-11-22 |
What was the administration route of drug 'IBUPROFEN'? | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | Oral | DrugAdministrationRoute | CC BY | 34809625 | 20,221,400 | 2021-11-22 |
What was the outcome of reaction 'Drug hypersensitivity'? | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | Recovered | ReactionOutcome | CC BY | 34809625 | 20,221,400 | 2021-11-22 |
What was the outcome of reaction 'Rash maculo-papular'? | Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.
BACKGROUND
Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated co... | Recovered | ReactionOutcome | CC BY | 34809625 | 20,221,400 | 2021-11-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Azotaemia'. | Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab.
Hemolytic Uremic Syndrome (HUS) is a constellation of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Shiga toxin-producing Escherichia coli- (STEC-) mediated HUS is a common cause of acute renal failure in child... | ECULIZUMAB, FUROSEMIDE | DrugsGivenReaction | CC BY | 34812294 | 20,166,902 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab.
Hemolytic Uremic Syndrome (HUS) is a constellation of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Shiga toxin-producing Escherichia coli- (STEC-) mediated HUS is a common cause of acute renal failure in child... | ECULIZUMAB, FUROSEMIDE | DrugsGivenReaction | CC BY | 34812294 | 20,166,902 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab.
Hemolytic Uremic Syndrome (HUS) is a constellation of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Shiga toxin-producing Escherichia coli- (STEC-) mediated HUS is a common cause of acute renal failure in child... | ECULIZUMAB, FUROSEMIDE | DrugsGivenReaction | CC BY | 34812294 | 20,166,902 | 2021 |
What was the administration route of drug 'FUROSEMIDE'? | Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab.
Hemolytic Uremic Syndrome (HUS) is a constellation of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Shiga toxin-producing Escherichia coli- (STEC-) mediated HUS is a common cause of acute renal failure in child... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34812294 | 20,166,902 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis of jaw'. | Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
OBJECTIVE
While risk factors of bisphosphonate (BP) associated osteonecrosis of the jaw have been properly analyzed, studies focusing on risk factors associated with denosumab (DNO) are sparse. The purp... | ALENDRONATE SODIUM, DENOSUMAB, IBANDRONATE SODIUM, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 34812959 | 20,164,745 | 2021-11-23 |
What was the outcome of reaction 'Osteonecrosis of jaw'? | Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
OBJECTIVE
While risk factors of bisphosphonate (BP) associated osteonecrosis of the jaw have been properly analyzed, studies focusing on risk factors associated with denosumab (DNO) are sparse. The purp... | Fatal | ReactionOutcome | CC BY | 34812959 | 20,164,745 | 2021-11-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
BACKGROUND
All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare b... | ARSENIC TRIOXIDE, PREDNISONE, TRETINOIN | DrugsGivenReaction | CC BY | 34814948 | 20,207,839 | 2021-11-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
BACKGROUND
All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare b... | ARSENIC TRIOXIDE, PREDNISONE, TRETINOIN | DrugsGivenReaction | CC BY | 34814948 | 20,678,394 | 2021-11-23 |
What was the outcome of reaction 'Differentiation syndrome'? | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
BACKGROUND
All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare b... | Recovered | ReactionOutcome | CC BY | 34814948 | 20,678,394 | 2021-11-23 |
What was the outcome of reaction 'Myocarditis'? | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
BACKGROUND
All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare b... | Recovered | ReactionOutcome | CC BY | 34814948 | 20,207,839 | 2021-11-23 |
What was the outcome of reaction 'Myopericarditis'? | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
BACKGROUND
All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare b... | Recovered | ReactionOutcome | CC BY | 34814948 | 20,678,394 | 2021-11-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry.
OBJECTIVE
Oral delayed-release dimethyl fumarate (DMF) is not recommended during pregnancy and should only be used if the potential benefit justifies the potential fetal risk. Although DMF was well tolera... | DIMETHYL FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34815321 | 20,340,164 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebrovascular accident'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Genital infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypogammaglobulinaemia'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inflammatory bowel disease'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lower respiratory tract infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningitis enteroviral'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial infarction'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oral infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psoriasis'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tooth infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxic skin eruption'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper respiratory tract infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
What was the administration route of drug 'RITUXIMAB'? | Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.
OBJECTIVE
To determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).
METHODS
This prospective observational study included all consecutive PwMS... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 34815322 | 20,151,644 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adulterated product'. | Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report.
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak throu... | TADALAFIL | DrugsGivenReaction | CC BY-NC | 34815718 | 20,164,587 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chorioretinopathy'. | Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report.
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak throu... | TADALAFIL | DrugsGivenReaction | CC BY-NC | 34815718 | 20,164,587 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect product formulation administered'. | Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report.
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak throu... | TADALAFIL | DrugsGivenReaction | CC BY-NC | 34815718 | 20,671,989 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product misuse'. | Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report.
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak throu... | TADALAFIL | DrugsGivenReaction | CC BY-NC | 34815718 | 20,659,055 | 2021 |
What was the administration route of drug 'TADALAFIL'? | Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report.
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak throu... | Oral | DrugAdministrationRoute | CC BY-NC | 34815718 | 20,164,587 | 2021 |
What was the outcome of reaction 'Chorioretinopathy'? | Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report.
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak throu... | Recovered | ReactionOutcome | CC BY-NC | 34815718 | 20,164,587 | 2021 |
What was the outcome of reaction 'Intentional product misuse'? | Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report.
Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak throu... | Recovered | ReactionOutcome | CC BY-NC | 34815718 | 20,659,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Glioblastoma multiforme metastasizing to the skin, a case report and literature review.
Glioblastoma Multiforme (GBM) is the most common primary central nervous system (CNS) malignancy in adults. It is very aggressive and is notorious for its fast and local invasion of nearby brain parenchyma. Consequently, the overall... | BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34815821 | 20,165,015 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Glioblastoma multiforme metastasizing to the skin, a case report and literature review.
Glioblastoma Multiforme (GBM) is the most common primary central nervous system (CNS) malignancy in adults. It is very aggressive and is notorious for its fast and local invasion of nearby brain parenchyma. Consequently, the overall... | BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34815821 | 20,165,015 | 2022-01 |
What was the dosage of drug 'FAVIPIRAVIR'? | Convalescent plasma therapy in obese severe COVID-19 adolescents: Two cases report.
In Indonesia, 175 cases resulted in death in children from March to December 2020. Studies regarding Convalescent Plasma Therapy's (CPT) safety and efficacy in children are scarce. Our case report was the first to write CPT in Indonesia... | UNK, FOR 3 DAYS | DrugDosageText | CC BY-NC-ND | 34815868 | 20,801,467 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug abuse'. | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | ACETAMINOPHEN, QUETIAPINE | DrugsGivenReaction | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug clearance decreased'. | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | ACETAMINOPHEN, QUETIAPINE | DrugsGivenReaction | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level increased'. | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | ACETAMINOPHEN, QUETIAPINE | DrugsGivenReaction | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | ACETAMINOPHEN, QUETIAPINE | DrugsGivenReaction | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | ACETAMINOPHEN, IBUPROFEN, QUETIAPINE FUMARATE | DrugsGivenReaction | CC BY-NC-ND | 34815870 | 20,236,262 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | ACETAMINOPHEN, QUETIAPINE | DrugsGivenReaction | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | ACETAMINOPHEN, QUETIAPINE | DrugsGivenReaction | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
What is the weight of the patient? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | 43 kg. | Weight | CC BY-NC-ND | 34815870 | 20,216,219 | 2021-11 |
What was the administration route of drug 'ACETAMINOPHEN'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
What was the administration route of drug 'IBUPROFEN'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34815870 | 20,216,219 | 2021-11 |
What was the outcome of reaction 'Drug abuse'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
What was the outcome of reaction 'Drug clearance decreased'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
What was the outcome of reaction 'Drug level increased'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
What was the outcome of reaction 'Drug-induced liver injury'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
What was the outcome of reaction 'Intentional overdose'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
What was the outcome of reaction 'Toxicity to various agents'? | Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity.
Acetaminophen hepatotoxicity is thought to be primarily caused by formation of the specific reactive metabolite N-acetyl-para-benzo-quinone imine (NAPQI). Malnourished individuals are at increased risk ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34815870 | 20,210,019 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Faecaloma'. | Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago.
A 72-year-old female patient used the oral phosphate binder lanthanum carbonate for 6 years, before discontinuing it after receiving a pancreas and kidney transplant. Now, 7 years after disco... | LANTHANUM CARBONATE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34815874 | 20,584,007 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric disorder'. | Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago.
A 72-year-old female patient used the oral phosphate binder lanthanum carbonate for 6 years, before discontinuing it after receiving a pancreas and kidney transplant. Now, 7 years after disco... | LANTHANUM CARBONATE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34815874 | 20,584,007 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastritis haemorrhagic'. | Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago.
A 72-year-old female patient used the oral phosphate binder lanthanum carbonate for 6 years, before discontinuing it after receiving a pancreas and kidney transplant. Now, 7 years after disco... | LANTHANUM CARBONATE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34815874 | 20,584,007 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago.
A 72-year-old female patient used the oral phosphate binder lanthanum carbonate for 6 years, before discontinuing it after receiving a pancreas and kidney transplant. Now, 7 years after disco... | LANTHANUM CARBONATE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34815874 | 20,592,802 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Reactive gastropathy'. | Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago.
A 72-year-old female patient used the oral phosphate binder lanthanum carbonate for 6 years, before discontinuing it after receiving a pancreas and kidney transplant. Now, 7 years after disco... | LANTHANUM CARBONATE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34815874 | 20,584,007 | 2021-11 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.